QUEEN MARY UNIVERSITY OF LONDON
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Private
- Established
- 1882-01-08
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.qmul.ac.uk
Withdrawal of Inhaled Corticosteroids in Patients With COPD in Primary Care
Phase 4
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2007-02-27
- Last Posted Date
- 2007-02-27
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 256
- Registration Number
- NCT00440687
- Locations
- π¬π§
Centre for Health Sciences, Queen Mary's School of Medicine and Dentistry, Barts and The London, 2 Newark Street,., London and Essex, London, United Kingdom
Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles
Phase 3
Completed
- Conditions
- Testicular Germ Cell TumorDrug/Agent Toxicity by Tissue/Organ
- First Posted Date
- 2006-05-11
- Last Posted Date
- 2013-08-12
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 210
- Registration Number
- NCT00324298
- Locations
- π¬π§
Basildon University Hospital, Basildon, England, United Kingdom
π¬π§Addenbrooke's Hospital, Cambridge, England, United Kingdom
π¬π§Essex County Hospital, Colchester, England, United Kingdom
Tamoxifen for the Prevention of Breast Cancer in High-Risk Women
- First Posted Date
- 2004-05-11
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 7154
- Registration Number
- NCT00002644
- Locations
- π¬π§
Queen Mary University of London, London, England, United Kingdom
Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer
- First Posted Date
- 2004-03-09
- Last Posted Date
- 2021-10-06
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 3864
- Registration Number
- NCT00078832
- Locations
- π¦πΊ
Newcastle Mater Hospital, Newcastle, New South Wales, Australia
π§πͺUniversity Hospitals, Leuven, Belgium
π¨π±Corporacion Nacional del Cancer, Santiago, Chile
Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ
- First Posted Date
- 2003-11-06
- Last Posted Date
- 2021-10-06
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 2980
- Registration Number
- NCT00072462
- Locations
- π¦πΊ
Australia, Newcastle, Australia
π¦πΉAustrian Breast & Colorectal Cancer Study Group, Vienna, Austria
π§πͺBelgium, Leuven, Belgium